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Abstract
Background: This study aimed to document the variation in technical efficiency of primary care (PC) practices in
delivering evidence-based cardiovascular risk management (CVRM) and to identify associated factors.
Methods: This observational study was based on the follow-up measurements in a cluster randomized trial.
Patients were recruited from 41 general practices in the Netherlands, involving 106 GPs and 1671 patients. Data on
clinical performance were collected from patient records. The analysis focused on PC practices and used a two-
stage data envelopment analysis (DEA) approach. Bias-corrected DEA technical efficiency scores for each PC practice
were generated, followed by regression analysis with practice efficiency as outcomes and organizational features of
general practice as predictors.
Results: Not all PC practices delivered recommended CVRM with the same technical efficiency; a significant
difference from the efficient frontier was found (p < .000; 95 % CI 1.018–1.041). The variation in technical efficiency
between PC practices was associated with training practice status (p = .026). Whether CVRM clinical tasks were
performed by a practice nurse or a GP did not influence technical efficiency in a statistical significant way
neither did practice size.
Conclusions: Technical efficiency in delivering evidence-based CVRM increased with having a training practice
status. Nurse involvement and practice size showed no statistical impact.
Keywords: Primary care, Cardiovascular risk management, Technical efficiency, Data envelopment analysis
Background
Across the world, health-care systems experience chal-
lenges due to ageing populations and increases in
chronic and lifestyle-related diseases [1] and rising
health-care costs [2]. Many policymakers believe that a
strong primary care is a crucial component of the
health-care system [3]. Primary care can only fulfil this
expectation, if evidence-based prevention and treatment
is provided in all eligible patients at reasonable costs.
This study focused on the delivery of evidence-based
prevention of cardiovascular disease in primary care.
Cardiovascular diseases (CVD) are common in the
Netherlands; the number of CVD-related hospital
admissions was almost 375,000 in 2012 [4]. Many pro-
grammes have focused on prevention of CVD and re-
lated disease, but still, they remain an important cause
of mortality and morbidity [5]. Cardiovascular risk man-
agement (CVRM) is largely provided in primary care
(PC) in the Netherlands. Although these efforts have
resulted in improved cardiovascular prevention care over
recent years, there is a substantial part of CVD patients
at risk in the Netherland that do not receive CVRM as
recommended by prevailing evidence-based guidelines
[6]. Little is known about the variation across general
practice organizations regarding the efficiency of deliver-
ing evidence-based CVRM. In case of improvement of
CRVM, substantial health benefits can be gained, while
containing costs of healthcare at the same time [7].
Decision makers (both clinicians and policymakers)
would be supported by insight into the efficiency of
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implementation of evidence-based CVRM in PC, as well
as knowledge of associated organizational factors that
influence the efficiency.
This study aimed at determining the technical effi-
ciency of PC practices delivering recommended CVRM
for patients with established cardiovascular disease and
especially aiming at identifying factors associated with
the variation in efficiency. Here, technical efficiency is
associated with the use of optimal procedures (i.e. opti-
mal implementation of procedures) and was defined as
the extent to which a PC practice delivers evidence-
based CVRM in relation to its inputs in terms of med-
ical labour. For this purpose, we used a two-stage data
envelopment analysis (DEA) approach.
DEA originates from management science and oper-
ation research and has mostly been used for benchmark-
ing efficiency of organizational units in, for example,
banking. It is a nonparametric approach determining a
piecewise linear efficiency frontier along the most effi-
cient organizational or decision-making units (DMUs)
by means of linear programming. Then, DEA compares
all inefficient DMUs to the efficient frontier. The PC
practices (DMUs) delivering recommended CVRM that
lay on the efficient frontier can be regarded as best
practices. As a benchmarking technique, the DEA
approach has gained much attention since it was first
proposed in the late 1970s by Charnes A, Cooper WW
and Rhodes E [8]. Presently, there are several thousand
recorded scientific contributions, some theoretical and
some applied [9]. DEA has been widely applied within
the health-care setting mostly with a focus on hospitals,
nursing homes and physicians (see for example [10–15]).
Other applications of DEA are within the context of
dialysis centres [16] and health systems [17]. A recent
systematic review by Pelone et al. [18] shows 39 DEA
applications in PC. According to Pelone et al. [18], DEA
has a number of features which make it an attractive
tool for efficiency measurement of PC delivery: ‘it can
handle effectively the existence of multiple primary
care resources (inputs) and multiple health outcomes
(outputs) in the transformation process. Furthermore,
it does not require strong assumptions about the
underlying technology linking the inputs to the out-
puts, and it measures efficiency in relative -instead of
absolute- terms.’
Methods
Study population and data
This study was based on the follow-up measurements in
a two-arm cluster randomized trial with a block design
[NCT00791362], which was executed from September
2008 until September 2012 [19]. Patients were recruited
from 41 general practices in the Netherlands, thereby
involving 106 general practitioners. Only patients with
established CVD, namely angina pectoris, acute myocar-
dial infarction, transient ischemic attack (TIA), ischemic
stroke, peripheral arterial disease, aortic aneurysm and
other chronic ischemic heart diseases, were included from
these PC practices. All these practices were enrolled in the
national accreditation programme (NHG-Praktijkaccredi-
tering) and used electronic medical records and Inter-
national Classification of Primary Care codes (ICPC
codes), a worldwide system to label conditions in primary
care [19]. All measures used for the analysis were derived
from patient records; for a detailed description of the
variables, we refer to the published study protocol [19].
This study focused on the delivery of evidence-based
prevention of cardiovascular disease in primary care,
which covers monitoring, counselling and preventive
medication. This study however did not show an effect on
primary outcomes [20].
The present study uses data from the trial by Nouwens
et al. [19], but it does not answer questions in the con-
text of the initial trial. For instance, it lumps data from
intervention and control groups for an observational
study. So, the present study is a newly post hoc devel-
oped study.
Data-analysis
The patient-based dataset was collapsed to make a data-
set of PC practice delivering CVRM summary statistics.
This led to PC practice average scores for both LDL
cholesterol and systolic blood pressure. The analyses on
the collapsed dataset consisted of a two-stage DEA
approach. DEA as a method of technical efficiency ana-
lysis was chosen in this study because it can deal with
multiple inputs and outputs and needs no assumptions
about the distribution between outputs and inputs. DEA
deals best with homogenous and independent units,
which perform the same function, such as PC practices
[21]. The first stage was the estimation of the technical
efficiency of general practice organizations in delivering
recommended CVRM, using bootstrapped DEA. The
second stage comprised of a regression analysis where
estimated bias-corrected efficiency scores (from the first
stage) were regressed on a set of preselected explanatory
and case-mix adjusting variables. For the DEA, 41 PC
practices were used. Technical efficiency in this study
reflects the ability of a practice organization to obtain
maximal output from a given set of inputs. In this case,
output is in terms of implementation of recommended
CVRM and input in terms of labour consumption (in
time) of health-care providers. This is consistent with
Farrell (technical) efficiency [9]. For an input orientation,
input-based Farrell efficiency scores (F) are ≤1, with 1
indicating technical efficiency. General practices with a
score of 1 are on the efficient frontier and used as
benchmark for the other practices. Scores <1 are
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considered less efficient. A score of, for example, .9 indi-
cates that it is possible to save 10 % off all inputs and
still produces the same outputs. An output-based Farrell
efficiency score (F≥1), for example 1.2, suggests that out-
put can be expanded by 20 % without spending add-
itional resources. In our study, this means that the
implementation of evidence-based CVRM in a PC prac-
tice with a Farrell efficiency score of, for example, 1.2
could be 20 % more successful without the consumption
of extra health-care resources by benchmarking itself to
one or a combination of PC practices on the efficient
frontier. So, Farrell efficiency values provide information
about relative improvement potential. In this study, the
following assumptions for DEA analysis were made:
 The DEA model runs under the assumption of
constant returns to scale (CRS) as we adhere a
policymaker perspective and assume that the
underlying technology is in a ‘steady state’.
 An output-oriented DEA model is performed to ex-
plore how each general practice could proportionally
maximize its outputs given the inputs provided and
move to a point on the efficient frontier.
 DEA analysis does not require trade-offs between
the various types of outputs or subjective judgments.
Under the assumption that all general practices were
homogeneous in their production technology
(CVRM) and assigning the same importance to
the inputs and outputs, no weight restrictions
were given in the model.
 DEA computes all the aforementioned values for
each PC practice, taking into account its efficient
peer PC practice(s) that use similar input–output
ratios, but at a more efficient level.
Stage 1
Measures of the DEA: the production function
The input variables
Input is defined here as the average amount of labour time
spent on a CVD patient within a period of 3 months,
which was operationalized in terms of consultations.
Labour in a PC practice can be performed by a GP, a prac-
tice nurse or a practice assistant.
The inputs of the primary care practices production
function were:
 Average number of consultations with a GP
 Average number of consultations with a practice
nurse
 Average number of consults with a practice assistant
For establishing the input variables, all consultations
per patient with each specific health-care worker were
counted within a period of 3 months. Only consultations
which were related to cardiovascular diseases, diabetes
mellitus and chronic obstructive pulmonary disease were
included. Also, the type of contact was taken into ac-
count, namely three different kinds were distinguished:
telephone consultation, normal consultation and home
visit. These were, respectively, counted and weighted
with a factor .5, 1 and 1.5, respectively [22].
The output variables
Output was defined in terms of implementation of
evidence-based CVRM as defined by prevailing clinical
practice guidelines. The outputs of the primary care
practices production function were:
 Performance indicator, based on prescribing of
recommended preventive medication
 LDL cholesterol
 Systolic blood pressure
The variables that were used to create the performance
indicator are statin and anticoagulants prescription. Both
medications need to be prescribed for nearly all included
patients, according to the CVRM guideline [23]. The ori-
ginal variables (statin and anticoagulants prescription)
are the basis of the performance indicator and have two
categories: 0 ‘no’ and 1 ‘yes’. The scale of the composited
measure (performance indicator) has two categories,
namely 1 for ‘imperfect adherence to the guidelines’
(meaning none or one of the medications recommended
by the guideline is prescribed) or 5 for ‘full adherence to
the guidelines’ (meaning all of the medications recom-
mended by the guideline are prescribed). The two cat-
egories (1 and 5) were chosen to reflect a 20 % relative
reduction in the risk of cardiovascular events for full
adherence to the guideline compared to imperfect
adherence [24, 25].
Under the assumption of an output-oriented CRS
DEA model that outputs should be increased, wrong
conclusions will arise for LDL and SBP. Therefore, both
variables were transformed. For both, a linear transform-
ation was used of the form: ydesirable = − yundesirable + v > 0
(−LDL plus 10; −SBP plus 300) [17, 26].
DEA measures efficiency relative to an estimate of the
efficient frontier.
The difference between the DEA score and the effi-
cient frontier is the relative (in)efficiency. This, however,
neglects the fact that the sample of DMUs (PC practices)
on which the DEA is performed underlays statistical
noise and random error. In fact, the obtained efficiency
scores are subject to uncertainty due to sampling vari-
ation. We therefore used a bootstrap DEA approach to
estimate the bias-corrected efficiency scores applying
1000 bootstrap replications as proposed by Simar and
Wilson [27]. We used the Benchmark package in R. This
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approach returns results directly as Farrell efficiency
measures [9, 28].
Stage 2
Variables in the regression analyses The dependent
variable was the estimated bias-corrected technical effi-
ciency score of general practices in providing evidence-
based CVRM. Explanatory variables were:
 Practice size: The size of a PC practice has been
found to influence efficiency [29].
 Training practice: These practices educate future
GPs, and therefore, their patients can benefit from
more attention and a culture that is orientated on
learning and reflection.
 Task CVRM practice nurse: If a practice nurse
performs CVRM clinical tasks instead of the GP,
research shows that chronic care is similar or better
although not necessarily less costly [30, 31].
Case-mix adjusting variables were:
 Age: The older the patient, the more complicated
treatments they have.
 Gender: Men have a predisposition for
cardiovascular disease.
 Diabetes mellitus: Co-morbidity might influence the
efficiency of the CVRM care [32, 33]. Diabetes is
included because structured care programmes for
patients with diabetes have been implemented
nationwide in the Netherlands. These structured
care programmes for diabetes have similarity with
the implementation of CVRM. PC practices that
have these structured diabetes programmes are
more likely to implement CVRM successful.
 Socio-economic status: Whether or not a practice
is located in a disadvantaged neighbourhood (a
neighbourhood with several infrastructural and
societal shortcomings) can influence CVRM care.
The second stage DEA analysis was performed within
the context of an assumed censoring data-generating
process (CDGP) (data piled up at a censoring point (i.e.
the efficient frontier)) and a fractional data-generating
process (FDGP). Under the assumption of a CDGP, usu-
ally, the bias-corrected output-oriented DEA scores were
regressed on explanatory variables using a Tobit regres-
sion. There is discussion that the efficiency scores are
not generated by a censoring process but are fractional
or proportional data [34]. Then, in the model considered
by Simar and Wilson [27], a truncated regression pro-
vides for consistent estimation in the second stage [34].
Both regression models (Tobit and truncated) were
performed using the statistical package STATA 13.1.
The truncated regression was considered the base
case, and these results are explicitly reported in the
main text and Table 2.
Results
In total, 41 PC practices were taken into analyses, repre-
senting 1671 cardiovascular patients. From the analysis,
4 patients were excluded due to missing values for the
performance indicator. Therefore, information of, in
total, 1667 patients were taken into analysis and used as
basis for the aggregated data on PC practice level. Table 1
shows descriptive data on variables (practice size, train-
ing practice, CVRM tasks for the practice nurse, sex,
age, diabetes, socio-economic status and DEA score) in
the analysis. The mean DEA and bootstrapped DEA
score were, respectively, 1.05 (5 % percentile 1; 95 % per-
centile 1.14) and 1.05 (5 % percentile 1.01; 95 % percent-
ile 1.12). The DEA analysis showed that 15 PC practices
(37 %) were on the efficient frontier and served as
benchmarks for the other practices (Table 1). The results
point to a significant difference from the efficient fron-
tier (p < .000; 95 % CI 1.018–1.041).
Truncated regression results are found in Table 2.
Practice size showed no significant impact on the effi-
ciency of PC practices with CVRM (p = .055). Being a
training practice had a significant positive effect
(negative coefficient) on the efficiency (p = .026).
Nurse involvement showed no impact on technical effi-
ciency (p = .280). Case-mix variable diabetes was found to
have a significant positive effect on efficiency of PC prac-
tices with CVRM. The Tobit regression found similar re-
sults (being a training practice, p = .042).
Discussion
This study provided insight into the technical efficiency
of delivering evidence-based CVRM and illustrates the
relevance of economic analysis of implementation in
health-care organizations.
The analysis showed that several general practice
organizations regarding their technical efficiency in
providing recommended CVRM deviated from the
efficient frontier. This implies that not all practices
provide evidence-based CVRM at optimal efficiency;
in fact, 15 of 41 practices provided evidence-based
CVRM at optimal efficiency. Increased technical effi-
ciency (better implementation of evidence-based
CVRM for the same resources) is related to training
practice status. We did not find evidence for the im-
pact of nurse involvement and practice size on tech-
nical efficiency.
In efficiency analysis, there are two important compet-
ing methods, stochastic frontier analysis (SFA) and DEA
[9]. According to Bogetoft and Otto, both methods have
their own strengths and weaknesses and differ from each
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1 2473 No Yes 66.30 63.0 10.9 No 1.105
2 2460 Yes Yes 70.93 60.0 15.6 No 1
3 7500 Yes Yes 66.55 74.5 32.7 Yes 1.084
4 3230 No Yes 68.46 78.4 32.4 No 1
5 13,000 Yes Yes 71.04 72.5 24.9 No 1.089
6 2600 Yes Yes 67.68 52.5 17.5 No 1.004
7 4600 Yes Yes 73.55 64.5 22.6 Yes 1.057
8 12,700 Yes Yes 68.79 61.8 17.6 No 1.026
9 3400 No Yes 66.76 69.6 28.3 No 1.092
10 3000 No Yes 64.44 47.2 16.7 No 1.059
11 5300 Yes No 66.49 79.1 25.6 No 1.010
12 4400 Yes Yes 68.43 73.5 6.0 No 1.035
13 6800 Yes Yes 67.57 62.9 0 No 1.042
14 3500 Yes Yes 66.27 63.6 0 No 1
15 3200 Yes Yes 65.53 70.6 14.7 No 1
16 2650 Yes Yes 70.31 61.9 21.4 No 1.047
17 2500 No No 69.90 68.8 37.5 No 1
18 4100 Yes Yes 72.47 64.4 4.4 No 1.078
19 2998 No No 66.90 59.0 2.6 No 1.049
20 2245 Yes Yes 61.40 80.0 33.3 Yes 1.005
21 2820 Yes Yes 69.71 60.5 26.3 No 1
22 2900 Yes No 65.00 71.9 18.8 No 1.025
23 2286 Yes Yes 72.40 68.0 12.0 No 1
24 2475 Yes Yes 66.29 45.7 31.4 No 1.012
25 1900 No Yes 65.13 37.5 50.0 Yes 1.014
26 2600 Yes No 69.32 38.7 35.5 No 1
27 2650 No Yes 57.00 75.0 25.0 Yes 1
28 2640 No Yes 75.00 57.6 15.2 No 1.036
29 3600 Yes Yes 68.82 78.9 5.3 No 1
30 4900 Yes No 67.52 73.9 13.0 No 1.000
31 2620 Yes Yes 68.25 67.9 17.9 No 1.004
32 8000 Yes Yes 69.84 64.9 16.2 No 1
33 2758 No Yes 65.87 82.6 15.2 No 1.009
34 3018 Yes Yes 67.21 70.6 32.4 No 1
35 2648 Yes Yes 71.94 62.9 17.1 No 1
36 3400 Yes Yes 69.71 58.5 17.1 No 1
37 2600 No Yes 67.94 57.6 6.1 No 1.120
38 6550 Yes Yes 67.64 66.7 24.0 Yes 1.111
39 1850 Yes Yes 72.33 61.5 30.8 No 1.045
40 7000 Yes Yes 66.94 94.4 8.3 No 1
41 2600 Yes Yes 72.50 70.6 14.7 No 1.039
aWhether or not a practice is located in a disadvantaged neighbourhood
bOutput-oriented Farrell technical efficiency scores
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other with regard to (1) the usage, SFA is used more
often in econometric efficiency analyses and DEA more
often in operation research efficiency analyses; (2) the
functional form of the efficient frontier, it is imposed a
priori as in SFA or it is obtained a posteriori from the
sample observations in an empirical way as in DEA and
(3) whether they follow a deterministic or a stochastic
approach (i.e. the distance of a DMU or PC practice
from the efficient frontier is entirely attributed to its in-
efficiency as in DEA or partly due to statistical noise and
random error, in addition to its inefficiency as in SFA)
[9, 18]. Our method expands conventional DEA in a
stochastic DEA which combines the nice features of
conventional DEA (like no assumptions on functional
form) and stochastic (SFA) methods. Stochastic DEA
makes it possible to use in an unbiased way the DEA
efficiency score in a multivariate regression analysis
that provides insight in which factors influence effi-
ciency of PC practices [27].
Some limitations of this study need to be discussed.
The variation of efficiency across PC practices can partly
be explained by the number of practices in the DEA. In-
cluding more practices would more accurately identify
the efficient frontier; however, more practices can also
cause some exogenous impacts of no interest or beyond
control affecting the results.
Despite these limitations and the complexities of the
methodology, we believe that the study has high rele-
vance. Implementation science has largely focused on ef-
fectiveness of implementation strategies, but their
efficiency is equally important. An effective yet costly
implementation programme is often of little practical
value, although it might contribute to scientific know-
ledge. DEA is a useful methodological tool for exploring
this, which adds to the methods for efficiency research
(see for example Pelone et al. [18]). For cardiovascular
risk management, we found that primary care practices
provide (‘produce’) evidence-based care at different
efficiency levels. This information could guide both
professional development and negotiations about reim-
bursement of cardiovascular care. Efficient practices
have a number of characteristics, or lack organizational
characteristics that are often assumed to be crucial, as
discussed below.
The size of general practices (that is, number of regis-
tered patients) has been found to have a number of con-
sequences. Higher practice size was associated with less
physician time per 1000 patients, which suggested po-
tential efficiency gains assuming equal quality [29]. The
latter was not confirmed by this study, but the under-
lying mechanisms are complex. It might be that our
study was underpowered (on PC level) with regard to
practice size (p = .055). Moreover, larger practices pro-
vide more structured chronic disease care [35] and may
therefore reach larger numbers of eligible patients, albeit
at the cost of lowered technical efficiency in those who
are diagnosed. This might have neutralized the impact of
practice on efficiency in our analysis.
The positive impact of training practice status on
technical efficiency was clear, but the practical rele-
vance of this finding may be limited as not all prac-
tices can become training practices. There may be
hidden resource use by GP trainees (that is, clinical
work that is provided without a cost), which were not
considered in the analysis. However, it is possible that
training practices are truly more efficient, because
these practices are regularly being assessed and stimu-
lated to improve their performance as precondition of
keeping their status as training practice. The effect may
also be based on the selection of specific professionals into
training practices, for instance professionals with higher
interest in organizational topics.
Previous analysis on a different data set showed that
more involvement of practice nurses was associated with
improved cardiovascular risk management [30]. We
found no evidence that this goes hand in hand with in-
creased technical efficiency in delivering evidence-based
CVRM. This is consistent with rigorous evaluations on
the involvement of nurses in clinical activities in primary
care, which found overall little impact of nurse involve-
ment on cost or efficiency of healthcare [22]. Previous
studies suggested that lower salary costs of nurses are
offset by longer consultations and lower threshold for
test ordering as compared to GPs.
Although it is generally assumed that co-morbidity
is associated with decreased efficiency, this study
found that the presence of diabetes actually enhanced
efficiency of health-care delivery structured diabetes
care has shown to be effective [32, 33] and is very
well established care in the Netherlands. It overlaps
partly with CVRM care which explains why ‘diabetes’
positively contributes to the efficiency of PC practice
applying CVRM.
Table 2 Results of truncated regression analysis
Bootstrapped truncated regression
(1000 replications)
Coefficient Bootstrapped p value
95 % confidence interval
Practice size 6.86e-06 −1.59e-07 .0000139 .055
CVRM task .024 −.0192 .066 .280
Training practice −.053 −.099 −.006 .026
Age .004 −.002 .010 .198
Gender .078 −.064 .221 .281
Diabetes −.177 −.351 −.004 .046
Socio-economic status .056 −.009 .121 .089
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Conclusions
We are careful in providing strong recommendations
for practice and policy on the basis of this study.
Nevertheless, we showed that efficiency of providing
evidence-based cardiovascular risk management can
be quantified, which identified substantial differences
between practices.
Considering the results as well as the emerging re-
search evidence on PC practice organization, we
conclude that practice size is associated with a range of
outcomes. Larger practice size seems to have both posi-
tive and negative effects. Involving nurses in clinical and
preventive activities has a number of advantages, but it
seems to have little impact on efficiency. The positive
impact of training status is consistent with other re-
search: ideally, all practices should become training
practices.
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